{"id":"https://openalex.org/W4362545443","doi":"https://doi.org/10.1158/1940-6207.c.6547574.v1","title":"Data from Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma","display_name":"Data from Targeting of CD40 and PD-L1 Pathways Inhibits Progression of Oral Premalignant Lesions in a Carcinogen-induced Model of Oral Squamous Cell Carcinoma","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362545443","doi":"https://doi.org/10.1158/1940-6207.c.6547574.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1940-6207.c.6547574.v1","doi":"https://doi.org/10.1158/1940-6207.c.6547574.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1940-6207.c.6547574.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1940-6207.c.6547574.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068195208","display_name":"Jose A. Monteiro de Oliveira Novaes","orcid":"https://orcid.org/0000-0001-5220-2710","observed_orcids":["https://orcid.org/0000-0001-5220-2710"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jose A. Monteiro de Oliveira Novaes","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049507860","display_name":"Taghreed Hirz","orcid":"https://orcid.org/0000-0001-9230-1756","observed_orcids":["https://orcid.org/0000-0001-9230-1756"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Taghreed Hirz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032866398","display_name":"Irene Guijarro","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Irene Guijarro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040693824","display_name":"Monique B. Nilsson","orcid":"https://orcid.org/0000-0002-0975-8833","observed_orcids":["https://orcid.org/0000-0002-0975-8833"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monique Nilsson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015115747","display_name":"Marlese A. Pisegna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marlese A. Pisegna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062224682","display_name":"Alissa Poteete","orcid":"https://orcid.org/0000-0002-6091-2840","observed_orcids":["https://orcid.org/0000-0002-6091-2840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alissa Poteete","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071785687","display_name":"Hampartsoum B. Barsoumian","orcid":"https://orcid.org/0000-0002-8209-6119","observed_orcids":["https://orcid.org/0000-0002-8209-6119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hampartsoum B. Barsoumian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078178224","display_name":"Jared J. Fradette","orcid":"https://orcid.org/0000-0001-6712-2860","observed_orcids":["https://orcid.org/0000-0001-6712-2860"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jared J. Fradette","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6712-2860","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043849312","display_name":"Limo N. Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Limo N. Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010884206","display_name":"Don Lynn Gibbons","orcid":"https://orcid.org/0000-0003-2362-3094","observed_orcids":["https://orcid.org/0000-0003-2362-3094"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Don L. Gibbons","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100337433","display_name":"Xiangjun Tian","orcid":"https://orcid.org/0000-0002-0179-9139","observed_orcids":["https://orcid.org/0000-0002-0179-9139"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiangjun Tian","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0179-9139","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100378341","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0002-5398-0802","observed_orcids":["https://orcid.org/0000-0002-5398-0802","https://orcid.org/0009-0006-4171-5397","https://orcid.org/0000-0002-8911-9555","https://orcid.org/0009-0003-0661-5954"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068859775","display_name":"Jeffrey N. Myers","orcid":"https://orcid.org/0000-0003-4767-3408","observed_orcids":["https://orcid.org/0000-0003-4767-3408","https://orcid.org/0000-0001-5008-8854"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey N. Myers","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4767-3408","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108666496","display_name":"Mark J. McArthur","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark J. McArthur","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032709498","display_name":"Diana Bell","orcid":"https://orcid.org/0000-0002-3531-8241","observed_orcids":["https://orcid.org/0000-0002-3531-8241"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana Bell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074756797","display_name":"William N. William","orcid":"https://orcid.org/0000-0001-5008-8854","observed_orcids":["https://orcid.org/0000-0001-5008-8854"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William N. William","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5048380048","display_name":"John Victor Heymach","orcid":"https://orcid.org/0000-0001-9068-8942","observed_orcids":["https://orcid.org/0000-0001-9068-8942"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John V. Heymach","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9068-8942","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.004399999976158142,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oral-squamous-cell-carcinoma","display_name":"oral squamous cell carcinoma","score":0.9769999980926514},{"id":"https://openalex.org/keywords/oral-premalignant-lesions","display_name":"oral potentially malignant disorders","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cd40-agonist","display_name":"CD40 agonist","score":0.875},{"id":"https://openalex.org/keywords/pd-1-pd-l1-blockade","display_name":"PD-1/PD-L1 blockade","score":0.902999997138977},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.9559999704360962},{"id":"https://openalex.org/keywords/ox40","display_name":"OX40","score":0.9210000038146973},{"id":"https://openalex.org/keywords/immunoprevention","display_name":"immunoprevention","score":0.9390000104904175},{"id":"https://openalex.org/keywords/4-nitroquinoline-1-oxide","display_name":"4-nitroquinoline 1-oxide","score":0.8640000224113464},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.5400000214576721},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.8529999852180481},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.8989999890327454},{"id":"https://openalex.org/keywords/m1-macrophages","display_name":"M1 macrophages","score":0.9760000109672546},{"id":"https://openalex.org/keywords/high-grade-dysplasia","display_name":"high-grade dysplasia","score":0.7459999918937683},{"id":"https://openalex.org/keywords/cervical-lymph-nodes","display_name":"cervical lymph nodes","score":0.5600000023841858},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.503000020980835}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6507341265678406},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6097375154495239},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5558743476867676},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5355854630470276},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4601022005081177},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4534783363342285},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.442716509103775},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42624813318252563},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36667346954345703},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2699572443962097},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.23564597964286804},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.18942153453826904}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1940-6207.c.6547574.v1","doi":"https://doi.org/10.1158/1940-6207.c.6547574.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1940-6207.c.6547574.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1940-6207.c.6547574.v1","doi":"https://doi.org/10.1158/1940-6207.c.6547574.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1940-6207.c.6547574.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3108257187","https://openalex.org/W4392722305","https://openalex.org/W2761773221","https://openalex.org/W3128214992","https://openalex.org/W2887965911","https://openalex.org/W2803719645","https://openalex.org/W3163752596","https://openalex.org/W2765238572","https://openalex.org/W3137337613","https://openalex.org/W3163479357"],"abstract_inverted_index":{"Abstract":[0],"We":[1,48],"have":[2],"previously":[3],"demonstrated":[4],"that":[5,40,227,243],"PD-1":[6,149],"blockade":[7,185,211],"decreased":[8],"the":[9,55,65,70,78,86,99,102,126,138,180,187,238,265,291,294],"incidence":[10],"of":[11,19,58,67,69,80,101,125,131,145,162,173,186,201,217,240,264,284],"high-grade":[12],"dysplasia":[13],"in":[14,35,85,98,152,213,237,252,277],"a":[15,168,198,214,278],"carcinogen-induced":[16],"murine":[17,279],"model":[18],"oral":[20,59,83],"squamous":[21],"cell":[22],"carcinoma":[23],"(OSCC).":[24],"It":[25],"remains":[26],"unknown,":[27],"however,":[28],"whether":[29],"there":[30],"are":[31],"additional":[32,44],"factors":[33],"involved":[34],"escape":[36],"from":[37],"immune":[38,56,91,127,174,285],"surveillance":[39],"could":[41],"serve":[42],"as":[43,248,260,262],"targets":[45],"for":[46,120,179,233],"immunoprevention.":[47],"performed":[49],"this":[50,253],"study":[51],"to":[52,142,147,164,167,270],"further":[53],"characterize":[54],"landscape":[57],"premalignant":[60],"lesions":[61],"(OPL)":[62],"and":[63,82,112,118,123,206,242],"determine":[64],"impact":[66],"targeting":[68,234],"PD-1,":[71],"CTLA-4,":[72],"CD40,":[73],"or":[74,151,157,191,293],"OX40":[75],"pathways":[76,92,296],"on":[77],"development":[79,239],"OPLs":[81,146,163],"carcinomas":[84],"4-nitroquinoline":[87],"1-oxide":[88],"model.":[89,280],"The":[90],"were":[93,116,177,268,297],"targeted":[94],"using":[95,105],"mAbs":[96],"or,":[97],"case":[100],"PD-1/PD-L1":[103,188,257,295],"pathway,":[104,267],"PD-L1\u2013knockout":[106],"(PD-L1ko)":[107],"mice.":[108],"After":[109],"intervention,":[110],"tongues":[111],"cervical":[113],"lymph":[114],"nodes":[115],"harvested":[117],"analyzed":[119],"malignant":[121],"progression":[122,161,273],"modulation":[124,176,286],"milieu,":[128],"respectively.":[129],"Targeting":[130],"CD40":[132,181,195,244,266,292],"with":[133,154,184,190],"an":[134],"agonist":[135,196],"mAb":[136],"was":[137,287],"most":[139],"effective":[140],"treatment":[141],"reduce":[143],"transition":[144],"OSCC;":[148],"alone":[150],"combination":[153],"CTLA-4":[155,193],"inhibition,":[156],"PD-L1ko,":[158],"also":[159],"reduced":[160],"OSCC,":[165,241],"albeit":[166],"lesser":[169],"extent.":[170],"Distinct":[171],"patterns":[172],"system":[175],"observed":[178,288],"agonists":[182,245],"compared":[183],"axis":[189],"without":[192],"blockade;":[194],"generated":[197],"lasting":[199],"expansion":[200],"experienced/memory":[202],"cytotoxic":[203],"T":[204,219],"lymphocytes":[205],"M1":[207],"macrophages,":[208],"whereas":[209],"PD-1/CTLA-4":[210],"resulted":[212],"pronounced":[215],"depletion":[216],"regulatory":[218],"cells":[220],"among":[221],"other":[222],"changes.":[223],"These":[224],"data":[225],"suggest":[226],"distinct":[228,282],"approaches":[229],"may":[230],"be":[231],"used":[232],"different":[235],"steps":[236],"merit":[246],"investigation":[247],"potential":[249],"immunoprevention":[250],"agents":[251],"setting.":[254],"Prevention":[255],"Relevance:":[256],"pathway":[258],"blockade,":[259],"well":[261],"activation":[263],"able":[269],"prevent":[271],"OPL":[272],"into":[274],"invasive":[275],"OSCC":[276],"A":[281],"pattern":[283],"when":[289],"either":[290],"targeted.":[298]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2023-04-06T00:00:00"}